Why is Korean skincare everywhere right now?

Because Americans bought $1.45 billion of it in the first six months of this year, up 41.5 percent, and the United States is now the largest foreign buyer of Korean cosmetics, a position it took from China last year. That is the demand side, and it is only a number.

The supply side is the interesting half. Korea did not get good at skincare because Korean women care more. It got good at it because of three pieces of infrastructure almost nobody outside the industry talks about, and because of one consequence of those three that nobody inside it likes to mention.

The numbers, briefly

Korea's Ministry of Food and Drug Safety reported $7.0 billion in cosmetics exports in the first half of 2026, up 27.3 percent, the largest first half on record. The United States took 20.7 percent of that, $1.45 billion, up 41.5 percent, crossing 20 percent for the first time. China fell 6.6 percent to $1.01 billion, and its share dropped from 19.6 percent to 14.4 percent.

It has not slowed. Separate trade figures from the Ministry of Trade, Industry and Energy put August exports at $1.31 billion, up 52.1 percent, the fastest monthly growth in thirty one months, and the year through August at $9.64 billion, up 30.8 percent. Skin care is roughly three quarters of the total.

One. Making a skincare product in Korea is unusually easy

This is the piece that explains the rest, and it is the least discussed.

Korea has an unusually deep contract manufacturing sector. A 2025 survey of 81 Korean cosmetics manufacturers put their combined revenue at about 11.1 trillion won, with the four largest accounting for a little over half of that and seventy-seven other firms sharing the rest. Cosmax, the largest by output, has gone from roughly 1,300 client brands in 2023 to about 5,000 now across its Korean, Chinese, Indonesian, American and Thai operations, of which around 1,500 are Korean brands.

What that means in practice is that you do not need a factory, and you do not need to hire a chemist. Korean law requires a registered responsible-selling manager, but the qualifying routes are wide: a medical or pharmacy licence, a relevant degree, an associate degree plus a year of experience, two years of manufacturing or quality-control work, or passing a national exam. In a company of ten or fewer people the founder can hold the role herself, provided she meets one of those standards.

Minimum order quantities are reported at around 3,000 units at Cosmax, against an industry norm closer to 10,000. No Korean manufacturer publishes its terms, so treat that as reported rather than confirmed.

The result is that Korea had roughly 4,400 registered cosmetics manufacturers, and just under 28,000 registered cosmetics-selling companies, in a country of 52 million people.

The best evidence that the small-brand route is real is not in anyone's marketing. It is in Cosmax's balance sheet. Between 2023 and the first half of this year its inventory grew from 218.4 billion won to 376.8 billion, and its accounts receivable more than doubled, from 271.5 billion to 555.8 billion. Korean business press attributes that to the production line changeovers short runs require, and to payment delays from small brands with thin balance sheets. The largest cosmetics manufacturer in the world by output is quietly financing its smallest customers.

One honest caveat. Contract manufacturing is not a Korean invention and Korea is not alone in it. Intercos in Italy earned about 44 percent of its roughly one billion euro revenue last year from emerging brands, and has been doing this since before anyone said K-beauty. Korea's difference is one of degree rather than kind. The degree is large, but it is a difference of degree.

Two. Korea has a legal category the United States does not have

This one surprised me, and it is the piece that actually shapes what ends up in the bottle.

Korea created a statutory category called functional cosmetics in 1999, effective in 2000. It sits between an ordinary cosmetic and a drug. There are now eleven defined categories, covering things like wrinkles, UV protection, hair loss, acne and stretch marks. The list expanded in 2017, and one of the additions covers products that help relieve the dryness and itching associated with atopic skin by supporting the skin barrier.

The United States has no equivalent. The FDA says so in as many words: the law does not recognise any category such as cosmeceuticals. A product is a drug, a cosmetic, or both. Which is why sunscreen is regulated as a drug here, and why it is not in any of my kits.

Two things are worth understanding about how the Korean category actually works, because it is easy to overstate.

First, it is not a licence to say anything. The claims are grammatically hedged in the Korean, closer to helps improve than to fixes, and several categories carry a mandatory printed line saying the product is not a drug.

Second, most products do not go through a real review. In the first half of 2022, the most recent split I could find, about 95 percent of functional cosmetics reached market through a notification filing against a published standard rather than a full evaluation. So the category is less an approval gate than a claim licence with a speed advantage attached.

Here is why it matters to you anyway. A country that writes barrier support into its cosmetics law is a country whose formulators have a commercial reason to think about the barrier. I cannot tell you the law caused the formulation, and I have not seen anyone establish that. What I can tell you is that the legal vocabulary and the product vocabulary line up, and that the American binary offers no equivalent shelf to aim at.

And the same system has a cost. Because meeting a published ingredient standard is sufficient, there is a live argument inside the Korean industry that the category freezes formulations at the notified concentration rather than pushing past it. That argument is worth taking seriously, and it cuts against everything I just said.

Three. Skin is treated as a project rather than a problem

I want to be careful here, because the version of this story everyone tells is about culture and most of it is vibes.

The measurable thing is not how many dermatologists Korea has. It is where skin work actually happens. In 2025, 285 new general practitioner clinics opened in Korea. Of those, 243 declared dermatology as their specialty, and of those 243, 158 filed no health insurance claims for skin disease at all.

That is national insurance data obtained by a member of the National Assembly. It describes one year's cohort rather than the whole country, so do not read it as a description of every clinic in Korea. But the direction is hard to miss. A large share of new clinics hanging out a dermatology sign are not treating skin conditions.

Aesthetic work in Korea has moved out of a medical specialty and into ordinary retail medicine. It is routine, and it is priced like a service rather than a treatment. It is also now the single biggest reason foreigners come to Korea for medical care. Dermatology accounted for 56.6 percent of the 1.17 million foreign patients Korea received in 2024, and dermatology patient numbers were up 194.9 percent in a year.

What I will not tell you is that Korean formulators design to clinic protocols. I looked for evidence of that and could not find any. What is observable is softer and still real. In a market where a laser appointment is unremarkable, the products that sell are the ones that sit comfortably alongside one.

What all of that actually produces

A great many companies, a high failure rate, and one number that needs an asterisk.

In 2024 the number of registered cosmetics-selling companies in Korea fell for the first time since records began in 2015, from 31,524 to 27,932. Some 8,831 companies came off the register that year, against 882 in 2020.

Here is the asterisk, because it matters and most coverage leaves it out. A 2024 rule change let the regulator cancel the registrations of companies that had already been struck off for tax reasons, and 6,292 of that year's removals were that administrative cleanup rather than fresh failures. The register was carrying a lot of shells and got tidied.

Even allowing for that, the underlying trend holds. Closures were climbing steeply before the rule change, and nothing since has reversed it.

The honest version is this. The infrastructure lowers the cost of trying. It does very little for the odds of surviving.

What this means if you are just trying to buy a moisturiser

It means the thing that got solved was supply, and the thing that did not was choosing.

Ten years ago finding Korean skincare took an importer and a forum thread. Now it takes a search bar. But four products that each work do not automatically work together, order matters, overlap matters, and two good actives can be a bad week for your skin. Thirty thousand companies did not make that easier. They made it considerably harder.

If exploring it yourself sounds like fun, this is the best moment there has ever been to do that. Korean reviews are a real resource once you can tell the sponsored ones apart, and one product at a time is how most people learn what their skin actually responds to.

If you would rather someone who reads Korean, talks to the people who make the products, and reads every ingredient list just hand you a routine, that is the other option and it is the one I built, from boutique Korean brands I have vetted down to the ingredients. The three minute skin quiz is the fastest way in.